|Bid||0.0000 x 3000|
|Ask||0.0000 x 1100|
|Day's range||0.6600 - 0.8479|
|52-week range||0.6600 - 17.1500|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||02 Nov 2022 - 07 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.00|
Codiak BioSciences, Inc. (CDAK) delivered earnings and revenue surprises of 61.54% and 701.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Bavarian Nordic (BVNRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
This week we saw the Codiak BioSciences, Inc. ( NASDAQ:CDAK ) share price climb by 13%. But that doesn't change the...